Cargando…
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients
Objective To investigate the effects on cardiovascular outcomes of drug interventions that increase high density lipoprotein levels. Design Meta-analysis. Studies reviewed Therapeutic benefit of niacin, fibrates, and cholesteryl ester transfer protein (CETP) inhibitors on cardiovascular events (all...
Autores principales: | Keene, Daniel, Price, Clare, Shun-Shin, Matthew J, Francis, Darrel P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103514/ https://www.ncbi.nlm.nih.gov/pubmed/25038074 http://dx.doi.org/10.1136/bmj.g4379 |
Ejemplares similares
-
Effect of niacin monotherapy on high density lipoprotein composition and function
por: Gordon, Scott M., et al.
Publicado: (2020) -
Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol
por: Kühnast, Susan, et al.
Publicado: (2013) -
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
por: Chapman, M. John, et al.
Publicado: (2010) -
CETP, LIPC, and SCARB1 variants in individuals with extremely high high-density lipoprotein-cholesterol levels
por: Lee, Chan Joo, et al.
Publicado: (2019) -
Lagrangian Fibrations
por: Huybrechts, D., et al.
Publicado: (2022)